The Gx and Biosimilars industry plays a critical role in global healthcare by ensuring access to affordable, high-quality medicines.

Last December, Griffin Bay Advisors celebrated a key milestone, successfully completing another impactful client engagement.

Griffin Bay Advisors has a proven track record of creating successful operating plans in the U.S. and internationally.

Every year, pharma companies spend billions of dollars on copay support programs to ensure patients can access critical therapies despite high insurance cost-sharing (co-pays and deductibles).

Pharma launches aren’t just critical milestones, they’re oxygen fueling industry growth.

This year, I have started a new page in my life with Griffin Bay Advisors, but Griffin Bay the place will forever be tied to my family and my story.